LADENBURG THALMANN FINANCIAL SERVICES INC. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 105 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$1,000
-75.0%
3,0000.0%0.00%
Q1 2019$4,000
+33.3%
3,0000.0%0.00%
Q4 2018$3,000
-62.5%
3,0000.0%0.00%
Q3 2018$8,000
-11.1%
3,0000.0%0.00%
Q2 2018$9,0000.0%3,0000.0%0.00%
Q1 2018$9,000
-52.6%
3,0000.0%0.00%
Q4 2017$19,000
-9.5%
3,0000.0%0.00%
Q3 2017$21,0000.0%3,0000.0%0.00%
Q2 2017$21,000
-63.8%
3,000
-52.0%
0.00%
-100.0%
Q1 2017$58,000
+132.0%
6,2500.0%0.00%
Q4 2016$25,000
+127.3%
6,250
+108.3%
0.00%
Q3 2016$11,000
-15.4%
3,0000.0%0.00%
Q2 2016$13,000
-7.1%
3,000
-2.3%
0.00%
Q1 2016$14,000
-54.8%
3,0720.0%0.00%
-100.0%
Q4 2015$31,000
+34.8%
3,0720.0%0.00%
Q3 2015$23,000
+187.5%
3,072
+1686.0%
0.00%
Q2 2015$8,000
+33.3%
1720.0%0.00%
Q1 2015$6,000
-14.3%
1720.0%0.00%
Q4 2014$7,000
+133.3%
1720.0%0.00%
Q3 2014$3,000
+50.0%
1720.0%0.00%
Q2 2014$2,000
+100.0%
172
+72.0%
0.00%
Q1 2014$1,0000.0%1000.0%0.00%
Q4 2013$1,0001000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2015
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders